Chinese Journal of Pharmacovigilance ›› 2025, Vol. 22 ›› Issue (2): 217-220.
DOI: 10.19803/j.1672-8629.20240547

Previous Articles     Next Articles

One Case of Red Man Syndrome Caused by Locally-Used Low-Dose Vancomycin

LI Xiaobo, ZHOU Guojian, HUANG Yuling, LI Haiqiao, CHEN Tingting   

  1. Department of Pharmacy, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai Guangdong 519020, China
  • Received:2024-08-01 Online:2025-02-17 Published:2025-02-17

Abstract: Objective To analyze the clinical characteristics and sensitization mechanisms of red man syndrome (RMS) induced by locally-used low-dose vancomycin, warn of associated risks and provide a reference for pharmacovigilance. Methods One case of RMS caused by low dose vancomycin locally used for prevention of surgical site infections (SSIs) was reported. The mechanism was studied based on ADR monitoring and a literature review while related pharmaceutical care was traced. Results According to the correlation evaluation of ADR, the score of Naranjo's scale and an analysis of sensitization mechanisms, vancomycin was considered to have caused RMS, so clinical pharmacists initiated adverse reaction monitoring and pharmaceutical care, and the symptoms of RMS were improved and disappeared. Conclusion Even locally-used low-dose vancomycin can potentially induce RMS, which is why pharmacovigilance is recommended.

Key words: Vancomycin, Red Man Syndrome(RMS), Surgical Site Infections (SSIL), Low-dose, Local Use, Adverse Drug Reaction

CLC Number: